- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 59/50 - Mandelic acid
Patent holdings for IPC class C07C 59/50
Total number of patents in this class: 43
10-year publication summary
|
2
|
4
|
4
|
2
|
3
|
0
|
1
|
2
|
4
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Gilead Sciences, Inc. | 2026 |
5 |
| BASF SE | 20758 |
2 |
| Sandoz AG | 1421 |
2 |
| Actavis Group PTC ehf | 477 |
2 |
| Teva Pharmaceuticals USA, Inc. | 906 |
2 |
| Zhejiang Jiuzhou Pharma Science & Technology Co., Ltd. | 9 |
2 |
| Boehringer Ingelheim International GmbH | 4701 |
1 |
| Kaneka Corporation | 4487 |
1 |
| Abbvie Inc. | 1800 |
1 |
| The Board of Trustees of the University of Illinois | 2682 |
1 |
| Takeda Pharmaceutical Company Limited | 2703 |
1 |
| Arch Pharmalabs Limited | 20 |
1 |
| Cadila Healthcare Limited | 321 |
1 |
| China State Institute of Pharmaceutical Industry | 21 |
1 |
| Cipla Limited | 467 |
1 |
| The First Affiliated Hospital, Third Military University, PLA | 1 |
1 |
| Krka, D.d., Novo Mesto | 95 |
1 |
| Laboratoriya Bio Zet, LLC | 4 |
1 |
| Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V. | 1768 |
1 |
| Nankai University | 232 |
1 |
| Other owners | 14 |